157 related articles for article (PubMed ID: 17066185)
41. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
[TBL] [Abstract][Full Text] [Related]
42. Practical points in urinary proteomics.
Thongboonkerd V
J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
[TBL] [Abstract][Full Text] [Related]
43. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
44. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
45. Enhanced detectability in proteome studies.
Sriyam S; Sinchaikul S; Tantipaiboonwong P; Tzao C; Phutrakul S; Chen ST
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):91-104. PubMed ID: 17140866
[TBL] [Abstract][Full Text] [Related]
46. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
47. Review of a current role of mass spectrometry for proteome research.
Chen CH
Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
[TBL] [Abstract][Full Text] [Related]
48. Stable feature selection for biomarker discovery.
He Z; Yu W
Comput Biol Chem; 2010 Aug; 34(4):215-25. PubMed ID: 20702140
[TBL] [Abstract][Full Text] [Related]
49. Biomarker discovery and related topics.
Guttman A
Electrophoresis; 2009 Apr; 30(7):1095. PubMed ID: 19373802
[No Abstract] [Full Text] [Related]
50. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
51. Recent advances in mass spectrometry-based peptidome analysis.
Hu L; Ye M; Zou H
Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
[TBL] [Abstract][Full Text] [Related]
52. Proteomic analysis of traumatic brain injury: the search for biomarkers.
Prieto DA; Ye X; Veenstra TD
Expert Rev Proteomics; 2008 Apr; 5(2):283-91. PubMed ID: 18466057
[TBL] [Abstract][Full Text] [Related]
53. Cardiovascular proteomic analysis.
Suzuki T; Nagai R
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):28-34. PubMed ID: 17350900
[TBL] [Abstract][Full Text] [Related]
54. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
[TBL] [Abstract][Full Text] [Related]
55. Statistical data processing in clinical proteomics.
Smit S; Hoefsloot HC; Smilde AK
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):77-88. PubMed ID: 18033744
[TBL] [Abstract][Full Text] [Related]
56. Peptidomics: the integrated approach of MS, hyphenated techniques and bioinformatics for neuropeptide analysis.
Boonen K; Landuyt B; Baggerman G; Husson SJ; Huybrechts J; Schoofs L
J Sep Sci; 2008 Feb; 31(3):427-45. PubMed ID: 18266258
[TBL] [Abstract][Full Text] [Related]
57. Proteomics, nanotechnology and molecular diagnostics.
Johnson CJ; Zhukovsky N; Cass AE; Nagy JM
Proteomics; 2008 Feb; 8(4):715-30. PubMed ID: 18297650
[TBL] [Abstract][Full Text] [Related]
58. Analytical strategies in lipidomics and applications in disease biomarker discovery.
Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
[TBL] [Abstract][Full Text] [Related]
59. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.
Hood BL; Stewart NA; Conrads TP
Clin Lab Med; 2009 Mar; 29(1):115-38. PubMed ID: 19389555
[TBL] [Abstract][Full Text] [Related]
60. Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine.
Ostrowski J; Wyrwicz LS
Expert Rev Mol Diagn; 2009 Sep; 9(6):623-30. PubMed ID: 19732006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
